Results 101 to 110 of about 2,455 (143)

Population-Based Assessment of Phenoconversion Potential in Switzerland: A Claims Data Study of Key Drug-Metabolizing Enzymes and Transporters. [PDF]

Pharmgenomics Pers Med
Roth MM, Bencastro A, Meier CR, Huber CA, Meyer Zu Schwabedissen HE, Allemann SS, Schneider C.   +6 more
europepmc   +1 more source

Higher glymphatic system activity is linked to longer prodromal stage in isolated REM sleep behavior disorder: a possible protective factor. [PDF]

NPJ Parkinsons Dis
Rottova V, Marecek S, Krajca T, Keller J, Sonka K, Dusek P, Nepozitek J.   +6 more
europepmc   +1 more source

Epigenetic ageing and the risk of Parkinson's disease. [PDF]

J Neurol Neurosurg Psychiatry
Peng X, Flores-Torres MH, Cortese M, Peng C, Hung AY, Schwarzschild M, Ascherio A, Bjornevik K.   +7 more
europepmc   +1 more source

Design and implementation of PharMe: a mobile application to return pharmacogenomic test results to patients. [PDF]

JAMIA Open
Slosarek T, Baum J, Frost B, Genchev N, Hermann L, Kunst S, Meister C, Schmidt M, Wagner S, Mashni SM, Lippert C, Böttinger EP, Owusu Obeng A.   +12 more
europepmc   +1 more source

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum. [PDF]

Eur J Nucl Med Mol Imaging
Arnaldi D, Mattioli P, Orso B, Raffa S, Lanfranchi F, Massa F, Iranzo A, Perissinotti A, Niñerola-Baizán A, Gaig C, Serradell M, Montini A, Mayà G, Muñoz-Lopetegi A, Liguori C, Fernandes M, Placidi F, Chiaravalloti A, Šonka K, Dušek P, Zogala D, Trnka J, Boeve BF, Miyagawa T, Lowe VJ, Miyamoto T, Miyamoto M, Puligheddu M, Figorilli M, Serra A, Hu MT, Klein JC, Bes F, Kunz D, Cochen De Cock V, De Verbizier D, Plazzi G, Antelmi E, Pizza F, Terzaghi M, Bossert I, Kulcsárová K, Garibotto V, Nicastro N, Lathuilière A, Bonanni L, Morbelli S, Roascio M, Arnulfo G, Pardini M.   +49 more
europepmc   +1 more source

Elevated plasma neurofilament light chain in isolated REM sleep behavior disorder: Associations with neurogenic orthostatic hypotension and implications for phenoconversion. [PDF]

J Parkinsons Dis
Calculli A, Di Martino D, Grillo P, Bellini G, Gagliardi S, Capriglia E, Fazio C, Comolli D, Malomo G, Regalbuto S, Maestri M, Hoxhaj D, Bonanni E, Ceravolo R, Cerri S, Pisani A, Terzaghi M.   +16 more
europepmc   +1 more source

Pharmacogenetic phenoconversion modeling of drug–drug–gene interactions on CYP2C19 activity: effects of comedication by genotype on escitalopram concentrations

Stingl J, Molden E, Hole K, Wollmann BM, Viviani R.   +4 more
europepmc   +1 more source

Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole. [PDF]

Schizophr Bull
Gras C, Piras M, Ranjbar S, Grosu C, Girardin FR, Vandenberghe F, Ansermot N, Grandjean C, Kaiser S, Gamma F, Plessen KJ, von Gunten A, Conus P, Crettol S, Eap CB.   +14 more
europepmc   +1 more source

Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study. [PDF]

Pharmacogenomics J
Görnert C, Scherf-Clavel M, Weber H, Roll SC, Eckert A, Reif A, Hahn M.   +6 more
europepmc   +1 more source

Safety and Efficacy of Idebenone in Isolated Rapid Eye Movement Sleep Behavior Disorder: A 3-Year Randomized Controlled Pilot Trial. [PDF]

Mov Disord
Li Y, Chen F, Luo N, Zhong M, Hu J, Yin Q, Ding Y, Niu M, Li B, Liu J.   +9 more
europepmc   +1 more source